Ophthalmic Devices - Northern Europe

  • Northern Europe
  • The Ophthalmic Devices market market in Northern Europe is predicted to achieve a revenue of US$0.53bn by 2024.
  • It is anticipated that the revenue will experience a Compound Annual Growth Rate (CAGR 2024-2029) of 3.52%, leading to a market volume of US$0.63bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue, amounting to US$14,000.00m in 2024.
  • In Northern Europe, the ophthalmic devices market is experiencing a surge in demand for advanced laser eye surgery technologies.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Northern Europe is experiencing steady growth, driven by customer preferences for advanced technology and a growing aging population. Customer preferences in the Ophthalmic Devices market in Northern Europe are shifting towards more advanced and innovative products. Consumers are increasingly seeking devices that offer superior performance, accuracy, and comfort. This trend is driven by the growing awareness of the importance of eye health and the desire for better visual outcomes. Additionally, the preference for non-invasive and minimally invasive procedures is also contributing to the demand for advanced ophthalmic devices. Trends in the Ophthalmic Devices market in Northern Europe include the increasing adoption of laser-assisted ophthalmic devices for refractive surgeries. Laser technology offers precise and efficient treatment options for conditions such as myopia, hyperopia, and astigmatism. The demand for these devices is driven by their ability to provide improved visual outcomes and faster recovery times compared to traditional surgical procedures. Another trend in the market is the growing popularity of diagnostic devices for early detection and monitoring of eye diseases. These devices enable healthcare professionals to identify and treat eye conditions at an early stage, leading to better patient outcomes and reduced healthcare costs. Local special circumstances in Northern Europe, such as the high prevalence of age-related eye diseases, contribute to the growth of the Ophthalmic Devices market. The region has a large aging population, which is more susceptible to conditions such as cataracts, glaucoma, and age-related macular degeneration. The increasing prevalence of these diseases is driving the demand for ophthalmic devices, including intraocular lenses, glaucoma drainage devices, and retinal implants. Additionally, the well-developed healthcare infrastructure and high healthcare expenditure in Northern Europe contribute to the accessibility and affordability of ophthalmic devices, further driving market growth. Underlying macroeconomic factors, such as the increasing disposable income and favorable reimbursement policies, also play a significant role in the development of the Ophthalmic Devices market in Northern Europe. The region's high disposable income allows consumers to afford advanced and expensive ophthalmic devices. Furthermore, favorable reimbursement policies by governments and private insurance companies encourage the adoption of ophthalmic devices by reducing the financial burden on patients. These factors create a conducive environment for market growth and innovation in the Ophthalmic Devices sector in Northern Europe.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)